Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Repare Therapeutics Inc. (RPTX) had Receiveable Turnover of 4.33 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$53.48M |
|
$-84.69M |
|
-- |
|
$53.48M |
|
$147.00M |
|
$-93.52M |
|
$10.27M |
|
$-83.25M |
|
$-83.25M |
|
$-84.69M |
|
$-84.69M |
|
$-84.69M |
|
$-84.69M |
|
$-93.52M |
|
$-96.76M |
|
42.41M |
|
42.41M |
|
$-2.00 |
|
$-2.00 |
|
| Balance Sheet Financials | |
$171.15M |
|
$2.29M |
|
$5.36M |
|
$176.51M |
|
$25.29M |
|
-- |
|
$0.09M |
|
$25.38M |
|
$151.13M |
|
$151.13M |
|
$151.13M |
|
42.51M |
|
| Cash Flow Statement Financials | |
$-76.44M |
|
$49.47M |
|
$0.54M |
|
$111.27M |
|
$84.72M |
|
$-26.55M |
|
$23.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-174.88% |
|
-174.88% |
|
-180.94% |
|
-155.67% |
|
-158.37% |
|
$-76.44M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
-- |
|
|
Receiveable Turnover |
4.33 |
84.27 |
|
-56.04% |
|
-56.04% |
|
-47.98% |
|
-56.04% |
|
$3.56 |
|
$-1.80 |
|
$-1.80 |
|